Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1 α expression in normoxic sickle mice: Microvascular implications

Dhananjay K. Kaul, Mary E. Fabry, Sandra M. Suzuka, Xiaoqin Zhang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Chronic inflammation is a salient feature of sickle cell disease (SCD) and transgenic-knockout sickle (BERK) mice. Inflammation is implicated in the activation of hypoxia-inducible factor-1α (HIF-1α) under normoxic conditions. We hypothesize that, in SCD, inflammation coupled with nitric oxide (NO) depletion will induce expression of HIF-1α, a transcription factor with wide-ranging effects including activation of genes for vasoactive molecules. To this end, we have examined the expression of HIF-1α in normoxic BERK mice expressing exclusively human α - and βS- globins, and evaluated the effect of fetal hemoglobin (HbF) in BERK mice (i.e., <1.0%, 20%, and 40% HbF). HbF exerts antisickling and anti-inflammatory effects. Here, we show that HIF-1α is expressed in BERK mice under normoxic conditions, accompanied by increased expression of its vasoactive biomarkers such as VEGF, heme oxygenase-1 (HO-1), and serum ET-1 levels. In BERK mice expressing HbF, HIF-1α expression decreases concomitantly with increasing HbF, commensurately with increased NO bioavailability, and shows a strong inverse correlation with plasma NO metabolites (NOx) levels. Reduced HIF-1α expression is associated with decreased HO-1, VEGF, and ET-1. Notably, arteriolar dilation, enhanced volumetric blood flow, and low blood pressure in normoxic BERK mice all show a trend toward normalization with the introduction of HbF. Also, arginine treatment reduced HIF-1α, as well as VEGF expression in normoxic BERK mice, supporting a role of NO bioavailability in HIF-1α activation. Thus HIF-1α expression in normoxic sickle mice is likely a consequence of chronic inflammation, and HbF exerts an ameliorating effect by decreasing sickling, increasing NO bioavailability, and reducing inflammation.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume304
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Hypoxia-Inducible Factor 1
Fetal Hemoglobin
Nitric Oxide
Inflammation
Vascular Endothelial Growth Factor A
Biological Availability
Heme Oxygenase-1
Sickle Cell Anemia
Globins
Hypotension
Transcriptional Activation
Arginine
Dilatation
Anti-Inflammatory Agents
Transcription Factors
Biomarkers

Keywords

  • Fetal hemoglobin
  • Hypoxia-inducible factor-1α
  • Inflammation
  • Nitric oxide
  • Oxidative stress
  • Sickle cell disease

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1 α expression in normoxic sickle mice : Microvascular implications. / Kaul, Dhananjay K.; Fabry, Mary E.; Suzuka, Sandra M.; Zhang, Xiaoqin.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 304, No. 1, 01.01.2013.

Research output: Contribution to journalArticle

@article{63d427cbaab54cfb829c9b6271ddc98b,
title = "Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1 α expression in normoxic sickle mice: Microvascular implications",
abstract = "Chronic inflammation is a salient feature of sickle cell disease (SCD) and transgenic-knockout sickle (BERK) mice. Inflammation is implicated in the activation of hypoxia-inducible factor-1α (HIF-1α) under normoxic conditions. We hypothesize that, in SCD, inflammation coupled with nitric oxide (NO) depletion will induce expression of HIF-1α, a transcription factor with wide-ranging effects including activation of genes for vasoactive molecules. To this end, we have examined the expression of HIF-1α in normoxic BERK mice expressing exclusively human α - and βS- globins, and evaluated the effect of fetal hemoglobin (HbF) in BERK mice (i.e., <1.0{\%}, 20{\%}, and 40{\%} HbF). HbF exerts antisickling and anti-inflammatory effects. Here, we show that HIF-1α is expressed in BERK mice under normoxic conditions, accompanied by increased expression of its vasoactive biomarkers such as VEGF, heme oxygenase-1 (HO-1), and serum ET-1 levels. In BERK mice expressing HbF, HIF-1α expression decreases concomitantly with increasing HbF, commensurately with increased NO bioavailability, and shows a strong inverse correlation with plasma NO metabolites (NOx) levels. Reduced HIF-1α expression is associated with decreased HO-1, VEGF, and ET-1. Notably, arteriolar dilation, enhanced volumetric blood flow, and low blood pressure in normoxic BERK mice all show a trend toward normalization with the introduction of HbF. Also, arginine treatment reduced HIF-1α, as well as VEGF expression in normoxic BERK mice, supporting a role of NO bioavailability in HIF-1α activation. Thus HIF-1α expression in normoxic sickle mice is likely a consequence of chronic inflammation, and HbF exerts an ameliorating effect by decreasing sickling, increasing NO bioavailability, and reducing inflammation.",
keywords = "Fetal hemoglobin, Hypoxia-inducible factor-1α, Inflammation, Nitric oxide, Oxidative stress, Sickle cell disease",
author = "Kaul, {Dhananjay K.} and Fabry, {Mary E.} and Suzuka, {Sandra M.} and Xiaoqin Zhang",
year = "2013",
month = "1",
day = "1",
doi = "10.1152/ajpheart.00296.2012",
language = "English (US)",
volume = "304",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1 α expression in normoxic sickle mice

T2 - Microvascular implications

AU - Kaul, Dhananjay K.

AU - Fabry, Mary E.

AU - Suzuka, Sandra M.

AU - Zhang, Xiaoqin

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Chronic inflammation is a salient feature of sickle cell disease (SCD) and transgenic-knockout sickle (BERK) mice. Inflammation is implicated in the activation of hypoxia-inducible factor-1α (HIF-1α) under normoxic conditions. We hypothesize that, in SCD, inflammation coupled with nitric oxide (NO) depletion will induce expression of HIF-1α, a transcription factor with wide-ranging effects including activation of genes for vasoactive molecules. To this end, we have examined the expression of HIF-1α in normoxic BERK mice expressing exclusively human α - and βS- globins, and evaluated the effect of fetal hemoglobin (HbF) in BERK mice (i.e., <1.0%, 20%, and 40% HbF). HbF exerts antisickling and anti-inflammatory effects. Here, we show that HIF-1α is expressed in BERK mice under normoxic conditions, accompanied by increased expression of its vasoactive biomarkers such as VEGF, heme oxygenase-1 (HO-1), and serum ET-1 levels. In BERK mice expressing HbF, HIF-1α expression decreases concomitantly with increasing HbF, commensurately with increased NO bioavailability, and shows a strong inverse correlation with plasma NO metabolites (NOx) levels. Reduced HIF-1α expression is associated with decreased HO-1, VEGF, and ET-1. Notably, arteriolar dilation, enhanced volumetric blood flow, and low blood pressure in normoxic BERK mice all show a trend toward normalization with the introduction of HbF. Also, arginine treatment reduced HIF-1α, as well as VEGF expression in normoxic BERK mice, supporting a role of NO bioavailability in HIF-1α activation. Thus HIF-1α expression in normoxic sickle mice is likely a consequence of chronic inflammation, and HbF exerts an ameliorating effect by decreasing sickling, increasing NO bioavailability, and reducing inflammation.

AB - Chronic inflammation is a salient feature of sickle cell disease (SCD) and transgenic-knockout sickle (BERK) mice. Inflammation is implicated in the activation of hypoxia-inducible factor-1α (HIF-1α) under normoxic conditions. We hypothesize that, in SCD, inflammation coupled with nitric oxide (NO) depletion will induce expression of HIF-1α, a transcription factor with wide-ranging effects including activation of genes for vasoactive molecules. To this end, we have examined the expression of HIF-1α in normoxic BERK mice expressing exclusively human α - and βS- globins, and evaluated the effect of fetal hemoglobin (HbF) in BERK mice (i.e., <1.0%, 20%, and 40% HbF). HbF exerts antisickling and anti-inflammatory effects. Here, we show that HIF-1α is expressed in BERK mice under normoxic conditions, accompanied by increased expression of its vasoactive biomarkers such as VEGF, heme oxygenase-1 (HO-1), and serum ET-1 levels. In BERK mice expressing HbF, HIF-1α expression decreases concomitantly with increasing HbF, commensurately with increased NO bioavailability, and shows a strong inverse correlation with plasma NO metabolites (NOx) levels. Reduced HIF-1α expression is associated with decreased HO-1, VEGF, and ET-1. Notably, arteriolar dilation, enhanced volumetric blood flow, and low blood pressure in normoxic BERK mice all show a trend toward normalization with the introduction of HbF. Also, arginine treatment reduced HIF-1α, as well as VEGF expression in normoxic BERK mice, supporting a role of NO bioavailability in HIF-1α activation. Thus HIF-1α expression in normoxic sickle mice is likely a consequence of chronic inflammation, and HbF exerts an ameliorating effect by decreasing sickling, increasing NO bioavailability, and reducing inflammation.

KW - Fetal hemoglobin

KW - Hypoxia-inducible factor-1α

KW - Inflammation

KW - Nitric oxide

KW - Oxidative stress

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=84871884178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871884178&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00296.2012

DO - 10.1152/ajpheart.00296.2012

M3 - Article

C2 - 23125209

AN - SCOPUS:84871884178

VL - 304

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 1

ER -